HEADER METAL BINDING PROTEIN 19-JUL-11 2LG1 TITLE SOLUTION STRUCTURE OF THE HUMAN AKAP13 PH DOMAIN AND STABILIZING DH TITLE 2 HELIX COMPND MOL_ID: 1; COMPND 2 MOLECULE: A-KINASE ANCHOR PROTEIN 13; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: PH DOMAIN RESIDUES 2164-2346; COMPND 5 SYNONYM: AKAP-13, AKAP-LBC, BREAST CANCER NUCLEAR RECEPTOR-BINDING COMPND 6 AUXILIARY PROTEIN, GUANINE NUCLEOTIDE EXCHANGE FACTOR LBC, HUMAN COMPND 7 THYROID-ANCHORING PROTEIN 31, LYMPHOID BLAST CRISIS ONCOGENE, LBC COMPND 8 ONCOGENE, NON-ONCOGENIC RHO GTPASE-SPECIFIC GTP EXCHANGE FACTOR, COMPND 9 PROTEIN KINASE A-ANCHORING PROTEIN 13, P47; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: AKAP13, BRX, HT31, LBC; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_COMMON: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)-ROSETTA; SOURCE 10 EXPRESSION_SYSTEM_VECTOR: PNIC28-BSA4 KEYWDS METAL BINDING PROTEIN EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR M.LENOIR,M.SUGAWARA,L.BALL,M.OVERDUIN REVDAT 3 14-JUN-23 2LG1 1 REMARK SEQADV REVDAT 2 13-AUG-14 2LG1 1 JRNL REMARK REVDAT 1 03-AUG-11 2LG1 0 JRNL AUTH M.LENOIR,M.SUGAWARA,J.KAUR,L.J.BALL,M.OVERDUIN JRNL TITL STRUCTURAL INSIGHTS INTO THE ACTIVATION OF THE RHOA GTPASE JRNL TITL 2 BY THE LBC ONCOPROTEIN. JRNL REF J.BIOL.CHEM. V. 3 215 2014 JRNL REFN ISSN 0021-9258 JRNL PMID 24993829 JRNL DOI 10.1074/JBC.M114.561787 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH M.SUGAWARA,S.B.WHITTAKER,S.BISHOP,L.BALL,M.OVERDUIN REMARK 1 TITL RESONANCE ASSIGNMENTS OF THE HUMAN AKAP13-PH DOMAIN AND REMARK 1 TITL 2 STABILIZING DH HELIX. REMARK 1 REF BIOMOL.NMR ASSIGN. V. 3 215 2009 REMARK 1 REFN ISSN 1874-2718 REMARK 1 PMID 19888694 REMARK 1 DOI 10.1007/S12104-009-9178-0 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : ARIA 2.1, ARIA 2.1 REMARK 3 AUTHORS : LINGE, O'DONOGHUE AND NILGES (ARIA), LINGE, REMARK 3 O'DONOGHUE AND NILGES (ARIA) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2LG1 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 22-JUL-11. REMARK 100 THE DEPOSITION ID IS D_1000102347. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 293 REMARK 210 PH : 7.00 REMARK 210 IONIC STRENGTH : 150.00 REMARK 210 PRESSURE : 1.00 ATM REMARK 210 SAMPLE CONTENTS : 0.5 MM [U-100% 13C; U-100% 15N] REMARK 210 AKAP13A_A10, 50.0 MM SODIUM REMARK 210 PHOSPHATE, 150.0 MM SODIUM REMARK 210 CHLORIDE, 0.1 MM SODIUM AZIDE, REMARK 210 90% H2O/10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 3D HNCO; 3D HN(CO)CA; CBCACONH REMARK 210 (H[N[CO[{CA|CA[C]}]]]); 3D REMARK 210 HNCACB; CCH TOCSY (HC_CH.TOCSY); REMARK 210 3D HCCH-TOCSY; 3D 1H-13C NOESY; REMARK 210 3D 1H-15N NOESY; 2D 1H-15N HSQC/ REMARK 210 HMQC REMARK 210 SPECTROMETER FIELD STRENGTH : 900 MHZ REMARK 210 SPECTROMETER MODEL : UNITYINOVA REMARK 210 SPECTROMETER MANUFACTURER : VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : CCPNMR ANALYSIS 2.1, NMRPIPE REMARK 210 NMRPIPE REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 HH TYR A 44 OE1 GLU A 64 1.59 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 2 PHE A 138 CE1 PHE A 138 CZ 0.157 REMARK 500 2 PHE A 138 CZ PHE A 138 CE2 -0.122 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 LYS A 4 44.77 -143.01 REMARK 500 1 ASP A 5 -166.28 58.66 REMARK 500 1 LEU A 13 55.24 -171.11 REMARK 500 1 ALA A 14 117.60 179.02 REMARK 500 1 LEU A 17 -38.14 -155.12 REMARK 500 1 LEU A 19 92.23 63.41 REMARK 500 1 VAL A 20 -83.84 43.80 REMARK 500 1 LYS A 21 43.69 -84.46 REMARK 500 1 VAL A 23 24.88 169.61 REMARK 500 1 ILE A 24 -153.63 -112.92 REMARK 500 1 ILE A 52 -168.93 -103.75 REMARK 500 1 MET A 55 -148.76 -80.28 REMARK 500 1 LEU A 71 99.41 -60.51 REMARK 500 1 GLN A 106 29.21 46.20 REMARK 500 1 GLN A 115 -51.63 -170.96 REMARK 500 1 LEU A 122 -170.93 -61.06 REMARK 500 1 LYS A 123 104.73 55.86 REMARK 500 1 LYS A 124 41.84 73.81 REMARK 500 1 MET A 144 -60.66 170.07 REMARK 500 1 THR A 145 -60.26 -170.44 REMARK 500 1 GLU A 148 74.85 58.41 REMARK 500 1 ASP A 177 -64.02 -93.61 REMARK 500 1 GLU A 178 -176.95 -58.55 REMARK 500 1 ASP A 179 -165.03 -67.84 REMARK 500 2 GLU A 9 1.49 -63.26 REMARK 500 2 ASP A 12 23.74 -76.76 REMARK 500 2 LEU A 13 -40.84 -167.48 REMARK 500 2 LEU A 17 -20.87 -178.54 REMARK 500 2 SER A 18 -154.62 -154.47 REMARK 500 2 LEU A 19 87.94 60.33 REMARK 500 2 VAL A 20 -77.99 40.12 REMARK 500 2 LYS A 21 37.56 -82.67 REMARK 500 2 VAL A 23 26.85 172.39 REMARK 500 2 ILE A 24 -157.94 -111.19 REMARK 500 2 MET A 55 -150.65 -110.15 REMARK 500 2 LEU A 71 95.30 -62.35 REMARK 500 2 GLN A 106 12.06 55.49 REMARK 500 2 LEU A 113 -31.65 69.07 REMARK 500 2 GLN A 115 -71.84 -128.26 REMARK 500 2 LYS A 116 -165.55 -103.94 REMARK 500 2 SER A 121 109.43 -52.48 REMARK 500 2 LEU A 122 -82.56 -42.67 REMARK 500 2 LYS A 123 132.78 -37.56 REMARK 500 2 MET A 144 -77.11 -133.93 REMARK 500 2 THR A 145 -52.89 -141.51 REMARK 500 2 GLU A 148 86.16 61.50 REMARK 500 2 ASP A 177 -62.54 -90.41 REMARK 500 2 GLU A 178 177.88 -59.35 REMARK 500 3 ASN A 6 2.43 -67.71 REMARK 500 3 LEU A 13 47.37 -178.91 REMARK 500 REMARK 500 THIS ENTRY HAS 500 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 GLN A 15 SER A 16 14 147.22 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 16195 RELATED DB: BMRB DBREF 2LG1 A 3 185 UNP Q12802 AKP13_HUMAN 2164 2346 SEQADV 2LG1 SER A 1 UNP Q12802 EXPRESSION TAG SEQADV 2LG1 MET A 2 UNP Q12802 EXPRESSION TAG SEQRES 1 A 185 SER MET THR LYS ASP ASN GLU VAL GLU GLN GLU ASP LEU SEQRES 2 A 185 ALA GLN SER LEU SER LEU VAL LYS ASP VAL ILE GLY ALA SEQRES 3 A 185 VAL ASP SER LYS VAL ALA SER TYR GLU LYS LYS VAL ARG SEQRES 4 A 185 LEU ASN GLU ILE TYR THR LYS THR ASP SER LYS SER ILE SEQRES 5 A 185 MET ARG MET LYS SER GLY GLN MET PHE ALA LYS GLU ASP SEQRES 6 A 185 LEU LYS ARG LYS LYS LEU VAL ARG ASP GLY SER VAL PHE SEQRES 7 A 185 LEU LYS ASN ALA ALA GLY ARG LEU LYS GLU VAL GLN ALA SEQRES 8 A 185 VAL LEU LEU THR ASP ILE LEU VAL PHE LEU GLN GLU LYS SEQRES 9 A 185 ASP GLN LYS TYR ILE PHE ALA SER LEU ASP GLN LYS SER SEQRES 10 A 185 THR VAL ILE SER LEU LYS LYS LEU ILE VAL ARG GLU VAL SEQRES 11 A 185 ALA HIS GLU GLU LYS GLY LEU PHE LEU ILE SER MET GLY SEQRES 12 A 185 MET THR ASP PRO GLU MET VAL GLU VAL HIS ALA SER SER SEQRES 13 A 185 LYS GLU GLU ARG ASN SER TRP ILE GLN ILE ILE GLN ASP SEQRES 14 A 185 THR ILE ASN THR LEU ASN ARG ASP GLU ASP GLU GLY ILE SEQRES 15 A 185 PRO SER GLU HELIX 1 1 ILE A 24 SER A 29 5 6 HELIX 2 2 LYS A 30 LYS A 46 1 17 HELIX 3 3 ALA A 62 LYS A 67 1 6 HELIX 4 4 SER A 156 GLU A 178 1 23 SHEET 1 A 2 MET A 53 ARG A 54 0 SHEET 2 A 2 MET A 60 PHE A 61 -1 O PHE A 61 N MET A 53 SHEET 1 B 7 VAL A 119 SER A 121 0 SHEET 2 B 7 ILE A 97 VAL A 99 -1 N LEU A 98 O ILE A 120 SHEET 3 B 7 LEU A 86 LEU A 94 -1 N VAL A 92 O VAL A 99 SHEET 4 B 7 LEU A 71 LYS A 80 -1 N VAL A 77 O VAL A 89 SHEET 5 B 7 VAL A 150 HIS A 153 -1 O HIS A 153 N PHE A 78 SHEET 6 B 7 GLY A 136 ILE A 140 -1 N LEU A 137 O VAL A 152 SHEET 7 B 7 ILE A 126 ARG A 128 -1 N ILE A 126 O ILE A 140 SHEET 1 C 2 GLN A 102 LYS A 104 0 SHEET 2 C 2 LYS A 107 ILE A 109 -1 O ILE A 109 N GLN A 102 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1